Living with an undiagnosed condition
May 17, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma
Samantha O’Shea explains some of the challenges she faces caring for her son, Ethan, who lives with a debilitating but …
Europe expands approved indication of Amgen’s Repatha in cardiovascular disease
May 17, 2018Sales and Marketing Amgen, Repatha, cardiovascular disease, pharma
Amgen has revealed that its PCSK9 inhibitor Repatha (evolocumab) has received approval from the European Commission in a new indication: …
Ipsen receives European first-line approval for Cabometyx
May 17, 2018Sales and Marketing Cabometyx, biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced …
FDA green lights first non-opioid therapy to manage symptoms of opioid withdrawal
May 17, 2018Sales and Marketing FDA, Lucemyra, opioid crisis, opioids, pharma
As the opioid epidemic continues to grip the US as the leading cause of deaths in those under the age …
UK MPs call for Brexit priority over pharma industry
May 17, 2018Medical Communications ABPI, UK government, biotech, drugs, pharma, pharmaceutical
A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure …
Roche gets NICE approval for advanced bladder cancer
May 17, 2018Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Though trial results for Tecentriq (atezolizumab) may not necessarily be going Roche’s way, after a combination treatment failure, the treatment …
Lilly’s galcanezumab soars in episodic cluster headache, but fails in chronic form
May 16, 2018Research and Development Eli Lilly, galcanezumab, headache, migraine, pharma
Eli Lilly has released new Phase 3 results for its CGRP inhibitor galcanezumab in the treatment of episodic cluster headache, …
Novartis’ top lawyer retires from role over botched Trump deal
May 16, 2018Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma
The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …
Pfizer scores approval for first Epogen/Procrit biosimilar in the US
May 16, 2018Research and Development, Sales and Marketing Epogen, Pfizer, Procrit, Retacrit, biosimilar, pharma FDA
Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …
How to treat colds? Target the person, not the virus
May 15, 2018Research and Development biotech, common cold, drugs, pharma, pharmaceutical
Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …
DIA: Pharmacovigilance conference
May 15, 2018Medical Communications, Research and Development dia
We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and …
New cancer clinical trial model promises to cut costs and development time
May 15, 2018Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, Cancer, MD AndersonCancer Center, clinical trials, pharma
Researchers from the University of Texas MD Anderson Cancer Center have been developing and testing a new model for the …
FDA issues warning letter over potential for poisoning at India plant
May 15, 2018Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical
The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …
Smell test targets asymptomatic malaria carriers
May 15, 2018Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical
Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …
Emergex secures funds in race to develop universal flu vaccine
May 15, 2018Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical
UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …
Lilly chalks up another acquisition with AurKa for $575m
May 14, 2018Manufacturing and Production, Sales and Marketing AurKa, Cancer, Eli Lilly, acquisition, oncology, pharma
Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …
Bringing the PRO to fruition
May 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma
Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …
Medigene and bluebird bio expand immunotherapy partnership to $1.5bn
May 14, 2018Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma
Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …
Takeda financials show why the Shire deal was needed
May 14, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …
Pharma unfazed by Trump price-reduction proposals
May 14, 2018Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical
President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
